Form 4 for ACRS Aclaris Therapeutics, Inc.
Accepted 2025-01-03 00:00:00 ET · period of report 2024-12-31 · accession 0001415889-25-000624 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-01-03 | 2024-12-31+ | ACRS | Monahan Joseph | CSO | F - Tax | — | -41.9K | 221.1K | -16% | — |
| DM | 2025-01-03 | 2024-12-31+ | ACRS | Monahan Joseph | CSO | M - OptEx | — | +91.1K | 245.5K | +59% | — |
| DM | 2025-01-03 | 2024-12-31+ | ACRS | Monahan Joseph | CSO | M - OptEx | $0.00 | -91.1K | 73.8K | -55% | $0 |
| D | 2025-01-03 | 2025-01-02 | ACRS | Monahan Joseph | CSO | A - Grant | $0.00 | +52.7K | 52.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-31 | F | D | 32,937 | — | 212,596 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. |
| 2 | Common | Common Stock | 2025-01-02 | F | D | 8,914 | — | 221,062 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. |
| 3 | Common | Common Stock | 2025-01-02 | M | A | 17,380 | — | 229,976 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. |
| 4 | Common | Common Stock | 2024-12-31 | M | A | 73,750 | — | 245,533 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. |
| 5 | Derivative | Restricted Stock Units | 2025-01-02 | M | D | 17,380 | $0.00 | 35,287 | D | — · — to — | 17,380 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. (F4) The shares underlying these restricted stock units vest as to 33% on January 2, 2025, 33% on January 2, 2026, and 34% on January 2, 2027, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date. |
| 6 | Derivative | Restricted Stock Units | 2025-01-02 | A | A | 52,667 | $0.00 | 52,667 | D | — · — to — | 52,667 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. (F4) The shares underlying these restricted stock units vest as to 33% on January 2, 2025, 33% on January 2, 2026, and 34% on January 2, 2027, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date. |
| 7 | Derivative | Restricted Stock Units | 2024-12-31 | M | D | 73,750 | $0.00 | 73,750 | D | — · — to — | 73,750 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. (F3) 50% of the shares underlying these restricted stock units vested or will vest on each of December 31, 2024 and December 31, 2025, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date. |